Kreiner Anna
J Med Humanit. 1995 Spring;16(1):55-68. doi: 10.1007/BF02276820.
In an era of increasing medical costs and cries for health care reform in the United States, the pharmaceutical industry has come under intense scrutiny. Ethical issues are inherent in the pharmaceutical marketplace, and there is a need to address the moral rights and responsibilities of drug manufacturers, consumers, health care professionals, and governmental agents in the production, distribution, regulation, and use of these products. A dual market system protecting individual rights to access and autonomy without placing an undue strain on societal resources would provide an adequate and equitable framework for an ethical pharmaceutical industry.
在美国,医疗成本不断攀升且医疗改革呼声日益高涨的时代,制药行业受到了严格审视。制药市场中存在着固有的伦理问题,有必要探讨药品制造商、消费者、医疗保健专业人员以及政府机构在这些产品的生产、分销、监管和使用方面的道德权利与责任。一个既能保护个人获取和自主权利,又不会给社会资源造成过度压力的双重市场体系,将为道德的制药行业提供一个充分且公平的框架。